⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3427593 | 0.80 | — | — | |
| SCHEMBL4345316 | 0.73 | — | — | |
| SCHEMBL19546235 | 0.71 | CYP1A2 (0.35) | — | |
| SCHEMBL10226234 | 0.67 | — | — | |
| SCHEMBL1119922 | 0.67 | — | — | |
| SCHEMBL23764776 | 0.65 | — | — | |
| SCHEMBL16274880 | 0.58 | — | — | |
| SCHEMBL1110136 | 0.58 | — | — | |
| SCHEMBL1110068 | 0.57 | — | — | |
| SCHEMBL24717956 | 0.57 | MAPK1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021222363-A1 | CYCLOALKYL PYRIMIDINES AS FERROPORTIN INHIBITORS | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2021-11-04 | — | — | WO | disclosed |
| WO-2021222483-A1 | METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2021-11-04 | — | — | WO | disclosed |